AR079237A2 - Proceso para la preparacion de derivados de dibenzo(b,f) azepina - Google Patents

Proceso para la preparacion de derivados de dibenzo(b,f) azepina

Info

Publication number
AR079237A2
AR079237A2 ARP100104442A ARP100104442A AR079237A2 AR 079237 A2 AR079237 A2 AR 079237A2 AR P100104442 A ARP100104442 A AR P100104442A AR P100104442 A ARP100104442 A AR P100104442A AR 079237 A2 AR079237 A2 AR 079237A2
Authority
AR
Argentina
Prior art keywords
formula
preparation
compound
azepina
dibenze
Prior art date
Application number
ARP100104442A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9885081&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR079237(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR079237A2 publication Critical patent/AR079237A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/26—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a double bond between positions 10 and 11
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Epoxy Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Un proceso para la preparacion de un compuesto de la formula (4) mediante hidrolisis de un compuesto de la formula (3) donde R1 es alquilo C1-4, donde el compuesto de la formula (3) se prepara mediante carbamoilacion de un compuesto de la formula (2) donde R1 es como se define para la formula (3), con un cianato de metal, donde la reaccion se efectua utilizando ácido acético, en presencia de un exceso sustancial de cianato de metal y en ausencia de un solvente adicional, donde dicho exceso substancial de cianato de metal es un exceso de por lo menos 0,2 equivalentes.
ARP100104442A 2000-02-07 2010-12-01 Proceso para la preparacion de derivados de dibenzo(b,f) azepina AR079237A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0002740.9A GB0002740D0 (en) 2000-02-07 2000-02-07 Organic compounds

Publications (1)

Publication Number Publication Date
AR079237A2 true AR079237A2 (es) 2012-01-04

Family

ID=9885081

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP010100515A AR029442A1 (es) 2000-02-07 2001-02-05 Un proceso para la produccion de derivados de dibenzo [b,f] azepina y compuestos intermediarios
ARP100104442A AR079237A2 (es) 2000-02-07 2010-12-01 Proceso para la preparacion de derivados de dibenzo(b,f) azepina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP010100515A AR029442A1 (es) 2000-02-07 2001-02-05 Un proceso para la produccion de derivados de dibenzo [b,f] azepina y compuestos intermediarios

Country Status (33)

Country Link
US (1) US7112673B2 (es)
EP (2) EP1265868B1 (es)
JP (1) JP4859322B2 (es)
KR (5) KR100931753B1 (es)
CN (2) CN1244563C (es)
AR (2) AR029442A1 (es)
AT (2) ATE505459T1 (es)
AU (1) AU767724B2 (es)
BR (1) BR0107922A (es)
CA (3) CA2639210C (es)
CO (1) CO5271705A1 (es)
CY (1) CY1111567T1 (es)
CZ (1) CZ301572B6 (es)
DE (2) DE60138271D1 (es)
DK (1) DK2067772T3 (es)
ES (2) ES2324900T3 (es)
GB (1) GB0002740D0 (es)
HU (1) HU229420B1 (es)
IL (3) IL150613A0 (es)
MX (1) MXPA02007629A (es)
MY (1) MY136474A (es)
NO (1) NO324949B1 (es)
NZ (1) NZ520329A (es)
PE (1) PE20011078A1 (es)
PL (2) PL214039B1 (es)
PT (2) PT2067772E (es)
RU (1) RU2303591C2 (es)
SI (1) SI2067772T1 (es)
SK (1) SK287217B6 (es)
TR (1) TR200201655T2 (es)
TW (1) TWI284638B (es)
WO (1) WO2001056992A2 (es)
ZA (1) ZA200206219B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670472B2 (en) 2001-10-09 2003-12-30 Max India Limited Process for the preparation of 10-methoxycarbamazepine
EP1302464A1 (en) * 2001-10-09 2003-04-16 Max India Limited Process for preparation of 10-methoxycarbamazepine
CA2486560A1 (en) 2002-06-14 2003-12-24 Taro Pharmaceuticals U.S.A., Inc. Method of preparing a 5h-dibenz[b,f]azepine-5-carboxamide
ITMI20040452A1 (it) 2004-03-09 2004-06-09 Clariant Lsm Italia Spa Processo per la preparazione di oxcarbazepina
AP2007004244A0 (en) 2005-05-10 2007-12-31 Intermune Inc Method of modulating stress-activated protein kinase system
ES2396051T3 (es) * 2006-04-26 2013-02-18 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal
US20090082335A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched oxcarbazepine
EP2296653B1 (en) 2008-06-03 2016-01-27 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
IN2015DN02296A (es) 2012-09-26 2015-08-21 Ranbaxy Lab Ltd
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
US11465978B2 (en) 2013-09-11 2022-10-11 The Administrators Of The Tulane Educational Fund Anthranilic amides and the use thereof
RU2692485C2 (ru) 2014-04-02 2019-06-25 Интермьюн, Инк. Противофиброзные пиридиноны

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847374A (en) * 1987-01-27 1989-07-11 Ciba-Geigy Corporation Process for the manufacture of N,N-(Dibenzohexatrienylene)ureas
DE4305502A1 (de) * 1993-02-23 1994-08-25 Basf Ag Ortho-substituierte 2-Methoxyiminophenylessigsäuremethylamide
IT1272897B (it) * 1995-01-13 1997-07-01 I F C Iniziative Finanziaarie Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
US6355680B1 (en) * 1996-02-20 2002-03-12 Exocell, Inc. Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
IT1283594B1 (it) 1996-04-12 1998-04-22 Trifarma Srl Derivati della 5h-dibenz- (b,f)-azepin-5-carbossiammide, loro preparazione e uso come sostanze ad azione medicinale
ATE344791T1 (de) * 1997-07-01 2006-11-15 Warner Lambert Co 2-(4-brom or 4-iod phenylamino)benzoesäurederivate und ihre anwendung als mek-inhibitoren
US6048856A (en) 1997-12-17 2000-04-11 Novo Nordisk A/S Heterocyclic compounds

Also Published As

Publication number Publication date
PL392476A1 (pl) 2010-11-22
PT1265868E (pt) 2009-07-15
TWI284638B (en) 2007-08-01
CN1394204A (zh) 2003-01-29
DK2067772T3 (da) 2011-07-18
ZA200206219B (en) 2003-04-04
KR20090102882A (ko) 2009-09-30
CN1244563C (zh) 2006-03-08
AU767724B2 (en) 2003-11-20
KR100931753B1 (ko) 2009-12-14
GB0002740D0 (en) 2000-03-29
HK1052501A1 (en) 2003-09-19
CA2395601C (en) 2010-01-05
KR20100018069A (ko) 2010-02-16
HUP0300243A3 (en) 2005-07-28
NO324949B1 (no) 2008-01-14
SK287217B6 (sk) 2010-03-08
CY1111567T1 (el) 2015-10-07
EP2067772A2 (en) 2009-06-10
EP1265868A2 (en) 2002-12-18
AR029442A1 (es) 2003-06-25
BR0107922A (pt) 2002-10-22
CZ301572B6 (cs) 2010-04-21
HU229420B1 (en) 2013-12-30
NZ520329A (en) 2003-11-28
IL150613A (en) 2010-05-17
HUP0300243A2 (hu) 2003-06-28
AU4237301A (en) 2001-08-14
PT2067772E (pt) 2011-07-13
KR101216285B1 (ko) 2012-12-28
IL188183A (en) 2011-02-28
EP1265868B1 (en) 2009-04-08
KR20080003016A (ko) 2008-01-04
EP2067772B1 (en) 2011-04-13
IL150613A0 (en) 2003-02-12
KR20080103608A (ko) 2008-11-27
PL356404A1 (en) 2004-06-28
NO20023575D0 (no) 2002-07-26
CZ20022676A3 (cs) 2002-11-13
DE60144456D1 (de) 2011-05-26
NO20023575L (no) 2002-07-26
US7112673B2 (en) 2006-09-26
US20030032800A1 (en) 2003-02-13
CA2639210A1 (en) 2001-08-09
MY136474A (en) 2008-10-31
PL217225B1 (pl) 2014-06-30
ATE427938T1 (de) 2009-04-15
KR100966209B1 (ko) 2010-06-25
MXPA02007629A (es) 2002-12-13
CA2724295A1 (en) 2001-08-09
ATE505459T1 (de) 2011-04-15
CO5271705A1 (es) 2003-04-30
JP2003521536A (ja) 2003-07-15
CA2724295C (en) 2011-07-26
RU2002123334A (ru) 2004-01-10
CA2639210C (en) 2011-05-03
SK11262002A3 (sk) 2003-02-04
CN100455572C (zh) 2009-01-28
PL214039B1 (pl) 2013-06-28
WO2001056992A2 (en) 2001-08-09
CN1721409A (zh) 2006-01-18
RU2303591C2 (ru) 2007-07-27
PE20011078A1 (es) 2001-11-16
KR20020071033A (ko) 2002-09-11
CA2395601A1 (en) 2001-08-09
EP2067772A3 (en) 2009-08-19
DE60138271D1 (de) 2009-05-20
ES2363490T3 (es) 2011-08-05
TR200201655T2 (tr) 2002-11-21
ES2324900T3 (es) 2009-08-19
WO2001056992A3 (en) 2002-01-24
JP4859322B2 (ja) 2012-01-25
SI2067772T1 (sl) 2011-08-31

Similar Documents

Publication Publication Date Title
AU2001252595A1 (en) Process for producing optically active sulfoxide derivative
ES2195510T3 (es) Derivados de imidazopiridina y procedimiento para prepararlos.
EP1690861A3 (en) A process for preparing duloxetine and intermediates for use therein
AU2003279363A1 (en) A process for the mononitration of alkanediols
ES2166093T3 (es) Procedimiento para la preparacion de compuestos de pirimidina.
CO5271705A1 (es) Derivados de dibenzo [b,f] azepina y su preparacion
EP1484301A4 (en) PROCESS FOR PREPARING A TRANS-4-AMINO-1-CYCLOHEXANCARBOXYLIC ACID DERIVATIVE
BR9407164A (pt) Processo para a preparação de um composto
PT1238977E (pt) Processo para a preparacao de um composto piridinometanolico
DK1045823T3 (da) Proces til fremstilling af visse benzoesyreforbindelser
BR0009453B1 (pt) processo para a preparação de um composto.
EP1132391A4 (en) PRODUCTION METHOD FOR 3-SULFONYLOXY-3-CEPHEM COMPOUNDS
BR0112501A (pt) Processo para a preparação de (-)mentol e compostos similares
BR9810685B1 (pt) processo para a prepraração de um composto.
DK709188A (da) Fremgangsmaade til fremstilling af et pyrazolderivat
AR051386A1 (es) Proceso para compuestos triciclicos que contienen atomos heterogeneos
PT93644A (pt) Processo para a preparacao de derivados do acido glutarico
DK0662475T3 (da) Fremgangsmåde til fremstilling af 2-perfluoralkyl-3-oxazolin-5-on.
MX9304677A (es) Procedimiento para la preparacion de compuestos defenol polihidrico.
DK1109782T3 (da) Fremgangsmåde til fremstilling af N-beskyttede azetidin-2-carboxylsyrer (AzeOH'er)
ES8201541A1 (es) Un procedimiento para la preparacion de nuevas guanilamidi- nas
DK1050526T3 (da) Fremgangsmåde til fremstilling af en tertiær alkylester af en carboxylsyre
BR0011490A (pt) Processo para a preparação de ésteres de 1,8-dissubstituìdos-1,3,4,9-tetrahidropirano (3,4-b)-indol-1-ácido acético em um solvente hidroxìlico
BR9810687B1 (pt) processo para a preparação de um composto derivado de 2-alquiltiobenzonitrila.
ATE244228T1 (de) Verfahren zur herstellung von chloroacetylaminothiazoleaceticsäure derivate

Legal Events

Date Code Title Description
FB Suspension of granting procedure